Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 60713-78-2 | MDL No. : | MFCD13704889 |
Formula : | C7H4ClN3O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LMGOHSUBTHHMHD-UHFFFAOYSA-N |
M.W : | 213.58 | Pubchem ID : | 14566226 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 52.75 |
TPSA : | 94.47 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.88 cm/s |
Log Po/w (iLOGP) : | 0.72 |
Log Po/w (XLOGP3) : | 1.02 |
Log Po/w (WLOGP) : | 1.42 |
Log Po/w (MLOGP) : | 0.42 |
Log Po/w (SILICOS-IT) : | 0.63 |
Consensus Log Po/w : | 0.84 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.22 |
Solubility : | 1.3 mg/ml ; 0.00607 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.59 |
Solubility : | 0.545 mg/ml ; 0.00255 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.82 |
Solubility : | 0.322 mg/ml ; 0.00151 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76% | at 0 - 23℃; | To a solution of 4-chloro-5-nitro-benzene-1 ,2-diamine (8.34 g, 44.4 mmol) and THF (625 ml_) was added carbonyl diimidazole (8.65 g, 53.3 mmol) at 0 0C. The reaction mixture was allowed to warm to 23 0C and was stirred for 20 h at this temperature. The reaction mixture was concentrated to a volume of 300 ml_ and 500 ml_ aqueous 1 M HCI was added, followed by water (total volume 2 L). The resulting suspension was cooled at 0 0C for 2 h, and the precipitate was collected and dried on the filter. It was then triturated with cold EtOAc (20 ml_) and rinsed EtOAc (2 x 5 ml_) to yield the titled compound (7.26 g, 76percent yield). MS (ESI/CI): mass calcd. for C7H4CIN3O3, 213.0; m/z found, 214.0 [M+H]+. |
[ 15950-17-1 ]
4-Chloro-N-methyl-2-nitroaniline
Similarity: 0.74
[ 2034-23-3 ]
5-Chloro-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.73
[ 5462-30-6 ]
N-(4,5-Dichloro-2-nitrophenyl)acetamide
Similarity: 0.73
[ 25781-92-4 ]
5-Chloro-2-nitro-N-phenylaniline
Similarity: 0.73
[ 23008-56-2 ]
N-(4-Chlorophenyl)-2-nitroaniline
Similarity: 0.71
[ 93-84-5 ]
5-Nitro-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.76
[ 2034-23-3 ]
5-Chloro-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.73
[ 5462-30-6 ]
N-(4,5-Dichloro-2-nitrophenyl)acetamide
Similarity: 0.73
[ 14088-98-3 ]
1-(3-Chlorophenyl)imidazolidin-2-one
Similarity: 0.67
[ 93-84-5 ]
5-Nitro-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.76
[ 15950-17-1 ]
4-Chloro-N-methyl-2-nitroaniline
Similarity: 0.74
[ 5462-30-6 ]
N-(4,5-Dichloro-2-nitrophenyl)acetamide
Similarity: 0.73
[ 25781-92-4 ]
5-Chloro-2-nitro-N-phenylaniline
Similarity: 0.73
[ 23008-56-2 ]
N-(4-Chlorophenyl)-2-nitroaniline
Similarity: 0.71
[ 93-84-5 ]
5-Nitro-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.76
[ 2034-23-3 ]
5-Chloro-1H-benzo[d]imidazol-2(3H)-one
Similarity: 0.73